.
A

s we approach the 2023 United Nations General Assembly, visionary leaders increasingly recognize artificial intelligence's (AI) immense potential to improve health and wellbeing. It is time for these leaders to seize this moment to improve medical research and treatment through responsible data sharing, enabling improved collaboration between patients and institutions.

Integrating AI into the healthcare field presents tremendous opportunities to reduce the burden of global healthcare costs and improve the wellbeing of our communities. By harnessing the power of AI and prioritizing patient access to data, we can revolutionize the diagnosis and management of complex conditions. Through a careful balance of privacy and data utilization, we can improve patient outcomes, enhance the overall quality of life, and empower patients to make informed choices about their healthcare.

AI's remarkable capabilities aid medical and research professionals diagnose diseases more efficiently, expanding their knowledge and abilities. Through advanced algorithms and machine learning techniques, AI can identify subtle patterns and signals that human observers may miss. 

Enabling information exchange is vital, allowing patients access to their data across different healthcare providers and commercial platforms. Patient permission to share this data with doctors is crucial for effective diagnosis and disease management, leading to improved outcomes. 

Identifying treatments and care options for patients requires comprehensive data. It comes through the broader sharing of non-identifying information among institutions like patient advocacy groups, medical research centers, businesses, and government researchers. 

Although patient advocacy groups often use patient registries to gather disease information, current systems suffer challenges due to their cumbersome architecture and the quantity of information requested. Also, these registries focus on post-diagnosis data collection and lack crucial details related to actions, behaviors, and symptoms before the disease is identified.

Furthermore, data sharing across comorbidities is limited with current systems. An area that deserves greater attention is the exponential growth of diet-related diseases.  Conditions like Crohn's and Colitis, celiac disease, and food allergies can be challenging to diagnose without a comprehensive understanding of timing and tracking patient eating habits, emergency room visits, and different medical interventions they have explored. 

Researchers, clinicians, and innovators would benefit from accessing comprehensive datasets encompassing patients' medical history, diet, and lifestyle. Incorporating these factors in data collection and sharing efforts will improve our understanding of the relationship between diseases and enable more effective interventions and treatments.

Millions spend endless hours in hospitals and billions of dollars on specialized food products to avoid adverse food-related events. They input their symptoms in search engines or explore eating disorder programs as they struggle to understand what is wrong with them.

Consider the journey of a young adult eosinophilic esophagitis (EOE) female who, for years, experienced severe vomiting and weight loss but was initially misdiagnosed with an eating disorder and high anxiety solely based on her gender. This example highlights the critical role that AI can play in improving patient outcomes and avoiding misdiagnoses. By harnessing the power of AI to analyze records from clinicians and behavioral health specialists, track eating habits, and cross-reference with comprehensive datasets, we can expedite the diagnosis of these diseases. In this instance, AI could have identified the underlying rare disease much earlier, saving the patient from mental and physical anguish, reducing financial costs, and easing the burden on the medical system. This patient journey exemplifies the potential of AI to revolutionize healthcare by enabling timely and accurate diagnoses, ultimately improving the lives of individuals.

Harlan Krumholz, MD, SM, Director, Yale School of Medicine Center for Outcomes Research and Evaluation, emphasizes the need for a systematic effort to learn from millions of patients' experiences to enhance medical treatments. In 2010, he advocated leveraging existing databases and billing records to ask the right questions and obtain valuable insight for improved patient care. Today, Krumholz is one of the most prominent advocates for empowering patients with their health data and equipping doctors with the necessary information for comprehensive analysis.

Early detection can lead to faster exploration of treatment options, resulting in more accurate and timely diagnoses. Ultimately, this reduces the burden on clinical and behavioral healthcare professionals and costs to society and improves patient care.

Today, our search engines, social media platforms, and online retailers are already tracking and, in many cases, exploiting our data for commercial use. Now is the time to give medical professionals and patients access to data and use it to achieve an early diagnosis and treatment that will improve their lives.

By fostering collaborative, responsibly sourced intelligence from our citizens and institutions, we can fully harness technology's potential as a powerful ally in advancing healthcare and achieving improved health outcomes for our communities. As noted, one area where we could see immediate advancement in solving and treating is food allergies or sensitivities, which impact one in four Americans, according to a study conducted by FARE, McKinsey, and Northwestern University. Similar trends are growing worldwide. Access to patient data in this context could make the most significant difference, but it is not limited to this disease category alone. Mental health and cognitive decline could be identified and addressed through similar access to comprehensive data sets.

In the rapidly evolving healthcare landscape, the integration of AI holds immense promise to transform how we diagnose, treat, and manage diseases. As government, nonprofit, and business leaders convene at the upcoming gathering, let us engage in meaningful discussions on ethical considerations, regulatory frameworks, and patient-centric approaches to ensure responsible and equitable AI implementation. Together, we can shape a future where AI-driven healthcare becomes a reality, empowering patients, improving health outcomes, and paving the way for a more efficient and accessible healthcare system.

About
Lisa Gable
:
Lisa Gable is a Diplomatic Courier Advisory Board member, Chairperson of World in 2050, and WSJ and USA Today best-selling author of "Turnaround: How to Change Course When Things Are Going South" (IdeaPress Publishing, October 5, 2021).
The views presented in this article are the author’s own and do not necessarily represent the views of any other organization.

a global affairs media network

www.diplomaticourier.com

Harness AI to Empower Healthcare Professionals and Patients

Illustration via Adobe Stock, created with Midjourney.

September 18, 2023

AI has immense potential to improve human health and wellbeing, being capable of helping medical and research professionals diagnose diseases more efficiently. Responsible information exchange privileging patient access will be vital to these efforts, writes W2050 Chairperson Amb. Lisa Gable.

A

s we approach the 2023 United Nations General Assembly, visionary leaders increasingly recognize artificial intelligence's (AI) immense potential to improve health and wellbeing. It is time for these leaders to seize this moment to improve medical research and treatment through responsible data sharing, enabling improved collaboration between patients and institutions.

Integrating AI into the healthcare field presents tremendous opportunities to reduce the burden of global healthcare costs and improve the wellbeing of our communities. By harnessing the power of AI and prioritizing patient access to data, we can revolutionize the diagnosis and management of complex conditions. Through a careful balance of privacy and data utilization, we can improve patient outcomes, enhance the overall quality of life, and empower patients to make informed choices about their healthcare.

AI's remarkable capabilities aid medical and research professionals diagnose diseases more efficiently, expanding their knowledge and abilities. Through advanced algorithms and machine learning techniques, AI can identify subtle patterns and signals that human observers may miss. 

Enabling information exchange is vital, allowing patients access to their data across different healthcare providers and commercial platforms. Patient permission to share this data with doctors is crucial for effective diagnosis and disease management, leading to improved outcomes. 

Identifying treatments and care options for patients requires comprehensive data. It comes through the broader sharing of non-identifying information among institutions like patient advocacy groups, medical research centers, businesses, and government researchers. 

Although patient advocacy groups often use patient registries to gather disease information, current systems suffer challenges due to their cumbersome architecture and the quantity of information requested. Also, these registries focus on post-diagnosis data collection and lack crucial details related to actions, behaviors, and symptoms before the disease is identified.

Furthermore, data sharing across comorbidities is limited with current systems. An area that deserves greater attention is the exponential growth of diet-related diseases.  Conditions like Crohn's and Colitis, celiac disease, and food allergies can be challenging to diagnose without a comprehensive understanding of timing and tracking patient eating habits, emergency room visits, and different medical interventions they have explored. 

Researchers, clinicians, and innovators would benefit from accessing comprehensive datasets encompassing patients' medical history, diet, and lifestyle. Incorporating these factors in data collection and sharing efforts will improve our understanding of the relationship between diseases and enable more effective interventions and treatments.

Millions spend endless hours in hospitals and billions of dollars on specialized food products to avoid adverse food-related events. They input their symptoms in search engines or explore eating disorder programs as they struggle to understand what is wrong with them.

Consider the journey of a young adult eosinophilic esophagitis (EOE) female who, for years, experienced severe vomiting and weight loss but was initially misdiagnosed with an eating disorder and high anxiety solely based on her gender. This example highlights the critical role that AI can play in improving patient outcomes and avoiding misdiagnoses. By harnessing the power of AI to analyze records from clinicians and behavioral health specialists, track eating habits, and cross-reference with comprehensive datasets, we can expedite the diagnosis of these diseases. In this instance, AI could have identified the underlying rare disease much earlier, saving the patient from mental and physical anguish, reducing financial costs, and easing the burden on the medical system. This patient journey exemplifies the potential of AI to revolutionize healthcare by enabling timely and accurate diagnoses, ultimately improving the lives of individuals.

Harlan Krumholz, MD, SM, Director, Yale School of Medicine Center for Outcomes Research and Evaluation, emphasizes the need for a systematic effort to learn from millions of patients' experiences to enhance medical treatments. In 2010, he advocated leveraging existing databases and billing records to ask the right questions and obtain valuable insight for improved patient care. Today, Krumholz is one of the most prominent advocates for empowering patients with their health data and equipping doctors with the necessary information for comprehensive analysis.

Early detection can lead to faster exploration of treatment options, resulting in more accurate and timely diagnoses. Ultimately, this reduces the burden on clinical and behavioral healthcare professionals and costs to society and improves patient care.

Today, our search engines, social media platforms, and online retailers are already tracking and, in many cases, exploiting our data for commercial use. Now is the time to give medical professionals and patients access to data and use it to achieve an early diagnosis and treatment that will improve their lives.

By fostering collaborative, responsibly sourced intelligence from our citizens and institutions, we can fully harness technology's potential as a powerful ally in advancing healthcare and achieving improved health outcomes for our communities. As noted, one area where we could see immediate advancement in solving and treating is food allergies or sensitivities, which impact one in four Americans, according to a study conducted by FARE, McKinsey, and Northwestern University. Similar trends are growing worldwide. Access to patient data in this context could make the most significant difference, but it is not limited to this disease category alone. Mental health and cognitive decline could be identified and addressed through similar access to comprehensive data sets.

In the rapidly evolving healthcare landscape, the integration of AI holds immense promise to transform how we diagnose, treat, and manage diseases. As government, nonprofit, and business leaders convene at the upcoming gathering, let us engage in meaningful discussions on ethical considerations, regulatory frameworks, and patient-centric approaches to ensure responsible and equitable AI implementation. Together, we can shape a future where AI-driven healthcare becomes a reality, empowering patients, improving health outcomes, and paving the way for a more efficient and accessible healthcare system.

About
Lisa Gable
:
Lisa Gable is a Diplomatic Courier Advisory Board member, Chairperson of World in 2050, and WSJ and USA Today best-selling author of "Turnaround: How to Change Course When Things Are Going South" (IdeaPress Publishing, October 5, 2021).
The views presented in this article are the author’s own and do not necessarily represent the views of any other organization.